Fidelity Investments
NBRV

Fidelity Investments’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Fidelity Investments’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-200
Closed -$346 – 5703
2023
Q1 		$346 Buy
+200
New +$336 ﹤0.01% 4825
2022
Q4 		– Sell
-8
Closed – – 5711
2022
Q3 		$0 Sell
8
-53,730
-100% -$226K ﹤0.01% 5651
2022
Q2 		$245K Hold
53,738
– – ﹤0.01% 3076
2022
Q1 		$564K Hold
53,738
– – ﹤0.01% 2947
2021
Q4 		$805K Hold
53,738
– – ﹤0.01% 2712
2021
Q3 		$1.6M Hold
53,738
– – ﹤0.01% 2618
2021
Q2 		$1.81M Hold
53,738
– – ﹤0.01% 2567
2021
Q1 		$2.23M Sell
53,738
-3,432
-6% -$213K ﹤0.01% 2451
2020
Q4 		$3.46M Hold
57,170
– – ﹤0.01% 2278
2020
Q3 		$7.62M Hold
57,170
– – ﹤0.01% 1921
2020
Q2 		$9.64M Buy
57,170
+32,756
+134% +$5.46M ﹤0.01% 1830
2020
Q1 		$3.51M Sell
24,414
-114
-0.5% -$34.9K ﹤0.01% 2041
2019
Q4 		$8.09M Buy
24,528
+4,689
+24% +$2.15M ﹤0.01% 1920
2019
Q3 		$9.92M Buy
19,839
+5,811
+41% +$3.28M ﹤0.01% 1830
2019
Q2 		$8.52M Buy
14,028
+982
+8% +$602K ﹤0.01% 1941
2019
Q1 		$7.96M Buy
13,046
+5,675
+77% +$3.1M ﹤0.01% 1941
2018
Q4 		$2.69M Buy
7,371
+6,171
+514% +$3.32M ﹤0.01% 2212
2018
Q3 		$810K Buy
+1,200
New +$851K ﹤0.01% 2496

Other funds holding NBRV

VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AA
Addison Advisors Middlebury, Vermont $452M AUM 14.62% 1-Year Est. Return

Fidelity Investments's NBRV Position: Q2 2023 in Review

Fidelity Investments sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q2 2023, closing a stake of 200 shares — an estimated $346 sold.

Fidelity Investments first reported a position in NBRV in Q3 2018 and held it in 18 quarters. The position peaked at $9.92M in Q3 2019. 9 funds tracked by Wall St. Rank hold NBRV as of Q2 2023.

  • Fidelity Investments reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q2 2023 after selling out during the quarter.
  • Fidelity Investments sold 200 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q2 2023, an estimated $346.
  • Fidelity Investments first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2018 and held it in 18 quarters.
  • Fidelity Investments's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $9.92M in Q3 2019.
  • 9 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.